Biocon Limited is a biopharmaceutical firm in India, engaged in developing, manufacturing and selling pharmaceutical products for oncology, diabetes and autoimmune diseases in the nation as well as abroad. The company has several sectors of operations such as small molecules, branded formulations, research services and more.
The company is manufacturing insulin lispro, insulin glargine, insulin aspart, recombinant human insulin, monoclonal antibodies, small molecules viz. generic formulations and active pharmaceutical ingredients and more, along with botanical products. Besides that, the company has branded formulation products under brands such as Insugen, BIOMAb, ALZUMAb, EGFR, Basalog and CANMAb. Biocon Limited has certifications such as ISO 9001, ISO 14001:2004, ISO 9001:2000, ISO 15189:2003 and OHSAS 18001:1999. The company has been developing its entire research system based upon small and large molecules, oligonucleotides and antibody-drug conjugates. Clinigene International Ltd and Syngene International Ltd are the two subsidiaries of Biocon Limited. The company has a global intervention in approximately 120 countries.
About Company Information:
Biocon Limited was incepted in 1978 and is headquartered in Bangalore, India. Biocon Limited was found when an Indian entrepreneur signed a joint venture with Ireland based firm Biocon Biochemicals Limited in 1978. The company started manufacturing and exporting enzymes to USA and Europe from 1979. Biocon Biochemicals Limited was acquired by Unilever plc and merged with Unilever’s subsidiary Quest International.
In 1990, the company enhanced its in-house research programme by introducing new technologies. In 1993, the R&D, along with manufacturing facilities of the company, was certified ISO 9001 by RWTUV, Germany. Syngene International Pvt. Ltd was incorporated by the company in 1994 as a Custom Research Company for addressing the exponentially increasing need for outsourced Research & Development in the pharmaceutical sector.
Developing an efficient manufacturing facility, Biocon Limited started to venture its initiatives for human healthcare in the medicine market and business since 1997. In 1998, Unilever had gone for a deal with ICI for selling its speciality chemicals division, which includes Quest International.
A totally automated submerged fermentation plant, for the first time in its history of operation, was commissioned by the company in 2000, for manufacturing speciality pharmaceuticals. Clinigene, India’s first Clinical Research Organisation for providing clinical research and development was commissioned by the company in 2000. US FSA approved Biocon Limited as India’s first pharmaceutical company to manufacture the cholesterol-lowering molecule lovastatin.
In 2005, a commercial agreement was signed by Biocon Limited for supplying insulin API to Asia, Africa and the Middle East. Nation’s largest biotechnology hub, having an integrated set up of manufacturing facilities and research laboratories with a spreading of 90 acres in Karnataka Industrial Areas Development Board—namely, Biocon Park was established by the company in 2006. Country’s largest multi-product Biologics facility was also established at Biocon Park.
An MoU was signed between Biocon and Neopharma, resulting as a joint venture firm Neobiocon in July 2007. A strategic partnership was established between the company and IATRICa, Inc for developing jointly a range of immunoconjugates regarding the immunotherapy of cancers and infectious diseases in January 2008.
BASALOG, long-lasting basal insulin for Type 1 & Type 2 Diabetics were introduced by Biocon Limited in 2009. Biocon Cell was launched as the resultant of the partnership between Biocon Limited and ISB for Innovation Management in the same year. AxiCorp GmbH, the German subsidiary of Biocon had been sold by the company in 2011, to its existing promoters and shareholders. ALZUMAb, was launched by Biocon Limited in 2013 for the psoriasis patients in India.
In 2014, CANMAb – Trastuzumab, a medicine for the treatment of breast cancer was launched by the company in India. A world-class premium devices facility was inaugurated by Biocon at Bangalore in 2015 along with the introduction of Basalog One in India. Mylan and Biocon jointly submitted a proposal for Biosimilar Trastuzumab to USFDA in 2016.
Biocon Limited declared that along with Mylan it is going to enhance the introduction of adalimumab biosimilar in Europe, as Mylan has an in-licensing arrangement with Fujifilm Kyowa Kirin Biologics.
How Biocon Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
Biocon Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
Biocon Ltd, Competitors and Sector Peers:
Aarey Drugs & Pharmaceuticals Ltd. AARDRU
Aayush Food & Herbs Ltd. AAYFOO
ABL Bio-Technologies Ltd. ABLBIO
Addlife Pharma Ltd. ADDPHA
Advik Laboratories Ltd. ADVLAB
Ahlcon Parenterals (India) Ltd. AHLPAR
Ajanta Pharma Ltd. AJAPHL
Aurobindo Pharma Ltd. AUROBP
Bharat Immunological & Biologicals Corporation Ltd. BHAIMM
Biofil Chemicals & Pharmaceuticals Ltd. BIOCHE
Biowin Pharma (India) Ltd. BIOPHA
Bliss GVS Pharma Ltd. BLIGVS
Brabourne Enterprises Ltd.[Amalgamated] RPGLIF
Brawn Biotech Ltd. BRAPHA
Brooks Laboratories Ltd. BROLAB
Cadila Healthcare Ltd. CADHEA
Caplin Point Laboratories Ltd. CAPPOI
Claris Lifesciences Ltd. CORELA
Colinz Laboratories Ltd. COLILA
Concord Drugs Ltd. CONDRU
Coral Laboratories Ltd. CORLAB
Desh Rakshak Aushdhalaya Ltd. DESRAK
Divi's Laboratories Ltd. DIVIL
Dolphin Laboratories Ltd. DOLLAB
Dr. Datsons Labs Ltd. AANLIF
Dr. Reddy's Laboratories Ltd. DR
Dujohn Laboratories Ltd. DUJLAB
Ganga Pharmaceuticals Ltd. GANPHA
Gennex Laboratories Ltd. GENLAB
Genomics Biotech Ltd. GENBIO
GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
Glenmark Pharmaceuticals Ltd. GLEPHL
IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
Ipca Laboratories Ltd. IPCLAB
Ishita Drugs & Industries Ltd. ISHDRU
J B Chemicals & Pharmaceuticals Ltd. JBCH
Jagsonpal Pharmaceuticals Ltd. JAGPHA
Jenburkt Pharmaceuticals Ltd. JENPHA
JK Pharmachem Ltd. JKPHAL
Jubilant Life Sciences Ltd. JUBILO
Jupiter Bioscience Ltd. JUPIBI
Kamron Laboratories Ltd. KAMLAB
Lincoln Pharmaceuticals Ltd. LINPHA
Madhuveer Com 18 Network Ltd. TOHPHA
Mahavir Advanced Remedies Ltd. INDAME
Makers Laboratories Ltd. MAKLAB
Mangalam Drugs and Organics Ltd. MANDRU
New Heaven Chemicals and Industries Ltd. TRAMED
NGL Fine - Chem Ltd. NGLFIN
Norris Medicines Ltd. NORMED
Novartis India Ltd. NOVAIN
Nutraplus India Ltd. NUTPRO
Oriental Remedies & Herbals Ltd. ORIREM
Ortin Laboratories Ltd. ORTLAB
Piramal Enterprises Ltd. NICPIR
Procter & Gamble Health Ltd. MERCLT
Ranbaxy Laboratories Ltd. RANLAB
RPG Life Sciences Ltd. RPGLI
Rubra Medicaments Ltd. RUBMED
Sun Pharmaceutical Industries Ltd. SUN28
Trans Asia Corporation Ltd. TRAASI
Yogi Healthcare Ltd. COREHE
Zenith Healthcare Ltd. ZENHEA
Zenlabs Ethica Ltd. SHRLAK
Zenotech Laboratories Ltd. ZENLAB
Biocon Biologics gets licence from Adagio Therapeutics for antibody treatment of COVID-19The Economic TimesNewsBotJul 26 2:16 AM
India must use, share Covid data transparently: Kiran Mazumdar-ShawThe Economic TimesNewsBotJul 23 2:51 AM
Biocon eyes market share expansion in developed, emerging markets: Kiran Mazumdar-ShawThe Economic TimesNewsBotJul 23 7:36 AM
Biocon shares down 0.61% as Nifty gainsThe Economic TimesNewsBotJul 22 8:26 AM
Shares of Biocon fall as Nifty gainsThe Economic TimesNewsBotJul 20 6:01 AM
Biocon shares down 0.83% as Nifty dropsThe Economic TimesNewsBotJul 19 5:26 AM
Shares of Biocon rise as Nifty dropsThe Economic TimesNewsBotJul 16 4:31 AM
Biocon shares up 0.99% as Nifty gainsThe Economic TimesNewsBotJul 14 4:46 AM
Biocon share price up 1.26 per centThe Economic Times